APT Pharmaceuticals is focused on the development of cyclosporine inhalation solution (CIS) for the prevention and treatment of chronic rejection in lung transplantation. The company has successfully enrolled a large, multi-center Phase III clinical trial evaluating the effect of CIS on chronic rejection and is preparing for commercialization of the product in the US and Europe.
Looking for a particular APT Pharmaceuticals employee's phone or email?
APT Pharmaceuticals Questions
The APT Pharmaceuticals annual revenue was $5.2 million in 2026.
Gregory Baigent is the Vice President of APT Pharmaceuticals.
7 people are employed at APT Pharmaceuticals.
APT Pharmaceuticals is based in Burlingame, California.
The NAICS codes for APT Pharmaceuticals are [32541, 325, 3254, 32].
The SIC codes for APT Pharmaceuticals are [283, 28, 2834].
Top APT Pharmaceuticals Employees
-
Gregory Baigent
Vice President at APT Pharmaceuticals
San Francisco, CA, US35+ -
Teresa st John
Executive Administrator and Office Manager at APT Pharmaceuticals
San Leandro, CA, US12 -
Cyrus L
Senior Quality Technician at APT Pharmaceuticals
New Territories, Hong Kong
Related Companies
